TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 68 filers reported holding TRANSLATE BIO INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $294,490,000 | +296.1% | 10,693,161 | +137.1% | 0.02% | +283.3% |
| Q1 2021 | $74,355,000 | -33.1% | 4,509,061 | -25.2% | 0.01% | -40.0% |
| Q4 2020 | $111,125,000 | +27.2% | 6,029,561 | -6.0% | 0.01% | +11.1% |
| Q3 2020 | $87,335,000 | -37.8% | 6,416,961 | -18.1% | 0.01% | -40.0% |
| Q2 2020 | $140,325,000 | +70.5% | 7,830,661 | -5.2% | 0.02% | +36.4% |
| Q1 2020 | $82,317,000 | +25.8% | 8,256,505 | +2.7% | 0.01% | +57.1% |
| Q4 2019 | $65,426,000 | -19.0% | 8,037,605 | -1.4% | 0.01% | -30.0% |
| Q3 2019 | $80,802,000 | -6.7% | 8,153,605 | +18.9% | 0.01% | 0.0% |
| Q2 2019 | $86,600,000 | +25.5% | 6,856,705 | +1.3% | 0.01% | +25.0% |
| Q1 2019 | $69,001,000 | +35.9% | 6,771,428 | +0.0% | 0.01% | +14.3% |
| Q4 2018 | $50,785,000 | -16.5% | 6,771,313 | +6.8% | 0.01% | 0.0% |
| Q3 2018 | $60,829,000 | -17.2% | 6,337,361 | +0.4% | 0.01% | -12.5% |
| Q2 2018 | $73,437,000 | – | 6,314,261 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,437,601 | $24,376,000 | 11.53% |
| DAFNA Capital Management LLC | 151,739 | $1,517,000 | 0.62% |
| Bain Capital Public Equity Management, LLC | 738,543 | $7,385,000 | 0.52% |
| Baupost Group | 6,491,287 | $62,393,000 | 0.48% |
| Rock Springs Capital Management LP | 1,009,179 | $10,092,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 276,639 | $2,766,000 | 0.32% |
| Cormorant Asset Management, LP | 454,550 | $4,546,000 | 0.30% |
| Artal Group S.A. | 600,000 | $6,000,000 | 0.16% |
| Perceptive Advisors | 500,000 | $5,000,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 367,744 | $3,677,000 | 0.03% |